Dual Incretin Peptide Analog
Tirzepatide is a fatty-acid-modified GIP/GLP-1 receptor agonist peptide analog represented in incretin-pathway research.
Product Procurement
Research-use catalog items with clear ordering, product context, and documentation support.
Tirzepatide — 60mg
$169.99
Product estimate
- FORMAT
- Lyophilized Powder
- NET VIAL CONTENT
- 60mg
- CATEGORY
- Peptides
- SKU
- ALS-TIRZ-60MG
In stock
Research Use Notice
For laboratory research use only. Not for human or animal use or consumption. Not for diagnostic, therapeutic, or veterinary use. Product documentation and certificates of analysis do not establish safety or suitability for these uses.
Product Intelligence
Tirzepatide Receptor & Peptide Profile
Fatty-acid-modified incretin peptide research material supplied as 60mg lyophilized tirzepatide.
60mg Lyophilized Tirzepatide
Supplied as 60mg lyophilized tirzepatide research material.
GIP / GLP-1 Receptor Context
Tirzepatide appears in receptor-pathway research involving GIP receptor pharmacology, GLP-1 receptor pharmacology, receptor-binding models, and cell-signaling assays.
- ClassGIP/GLP-1 receptor agonist peptide analog
- IdentifierPubChem CID 166567236
- Presentation60mg lyophilized material
Documentation
Verification & Documentation
Documentation is handled by product and lot. Use Standards to search for a matching record; if none appears, contact support with the product name, SKU, and lot number.